Related Experiment Videos
Basal ganglia iron content in Parkinson's disease measured with magnetic resonance
F Q Ye1, P S Allen, W R Martin
1Department of Applied Sciences in Medicine, University of Alberta, Edmonton, Canada.
Abstract:
The possibility of using magnetic resonance (MR) to evaluate the severity of the pathological changes of Parkinson's disease (PD) is suggested by the known accumulation of iron in the basal ganglia in PD and the reduced signal evident from this area with conventional T2-weighted MR imaging. To improve the specificity of MR for the measurement of tissue iron content, we have developed a method that quantifies the effects of paramagnetic centers sequestered inside cellular membranes, based on the echo time dependence of the decay of transverse magnetization caused by the local field inhomogeneities which are due to intracellular iron. This method enables an index of local tissue iron content to be calculated for structures of the basal ganglia. We report here the application of this method to a series of patients with PD (n = 12) and of normal, age-matched controls (n = 13). Our objective was to determine whether this measurement of basal ganglia iron concentration correlates with the presence and severity of PD. We observed a significant increase in iron content in both the putamen and pallidum in PD as well as a correlation with the severity of clinical symptomatology. More severely affected patients had a higher iron content in both of these structures. Our results suggest that this MR measurement may provide a noninvasive method of measuring the severity of the pathological changes underlying PD.
Insights
Magnetic resonance imaging (MRI) can assess Parkinson's disease (PD) severity by measuring increased iron in the basal ganglia. Higher iron levels in these brain regions correlate with more severe PD symptoms, offering a noninvasive diagnostic tool.
Area of Science:
- Neuroimaging
- Neurology
- Biophysics
Background:
- Parkinson's disease (PD) is associated with iron accumulation in the basal ganglia.
- Conventional T2-weighted MRI shows reduced signal in these areas, suggesting iron presence.
- Existing methods lack specificity for quantifying intracellular iron content.
Purpose of the Study:
- To develop and apply a novel MR method for quantifying intracellular iron in the basal ganglia.
- To determine if basal ganglia iron concentration correlates with PD presence and severity.
- To evaluate MR as a noninvasive tool for assessing PD pathology.
Main Methods:
- Developed an MR technique measuring echo time dependence of transverse magnetization decay.
- Quantified local tissue iron content in basal ganglia structures (putamen, pallidum).
- Applied the method to patients with PD (n=12) and age-matched controls (n=13).
Main Results:
- Observed a significant increase in iron content in the putamen and pallidum of PD patients.
- Found a positive correlation between basal ganglia iron concentration and PD clinical severity.
- More severely affected patients exhibited higher iron levels in these brain regions.
Conclusions:
- The developed MR method accurately quantifies basal ganglia iron.
- Increased basal ganglia iron is a biomarker for Parkinson's disease.
- This MR technique offers a noninvasive approach to measure PD severity and pathological changes.